The aim of this multicenter study was to investigate the prognostic role of neutrophil-to-lymphocyte ratio (NLR) and to validate the NLR cutoff of 3 in a large multi-institutional cohort of patients with primary T1 HG/G3 non-muscle-invasive bladder cancer (NMIBC).
Vartolomei, M.d., Ferro, M., Cantiello, F., Lucarelli, G., Di Stasi, S., Hurle, R., et al. (2018). Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer. CLINICAL GENITOURINARY CANCER, 16(6), 445-452 [10.1016/j.clgc.2018.07.003].
Validation of Neutrophil-to-lymphocyte Ratio in a Multi-institutional Cohort of Patients With T1G3 Non–muscle-invasive Bladder Cancer
Lucarelli G.;Di Stasi S.
;Bove P.;
2018-01-01
Abstract
The aim of this multicenter study was to investigate the prognostic role of neutrophil-to-lymphocyte ratio (NLR) and to validate the NLR cutoff of 3 in a large multi-institutional cohort of patients with primary T1 HG/G3 non-muscle-invasive bladder cancer (NMIBC).File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
CLINICAL GENITOURINARY CANCER 2018.pdf (300.8 KB); .pdf
accesso aperto
Licenza:
Copyright dell'editore
Dimensione
720.98 kB
Formato
Adobe PDF
|
720.98 kB | Adobe PDF | Visualizza/Apri |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
